Delivery Order SPE2DB20D1100-SPE2DB24FD4Q1

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,840.32, is for the delivery of REFRESH PLUS 0.5% EYE DROPS 30S, a pharmaceutical product. The contract has an ultimate completion date of October 10, 2024 and is a firm-fixed-price delivery order. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,065.60 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of REFRESH PLUS 0.5% EYE DROPS UD 70S, a pharmaceutical product, with a ceiling value of $1,675.53 and a completion date of November 27, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.34 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S", with a period of performance through May 10, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,510.50 firm-fixed-price delivery order contract covers the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S", a medical commodity. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,741.59 firm fixed-price delivery order is for "REFRESH PLUS 0.5% EYE DROPS UD 70S", a pharmaceutical product. The contract has an ultimate completion date of March 6, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,745.72 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" medical products. The contract has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,168.13 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has a completion date of February 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,658.52, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS UD 70S" medical supplies. It is a firm fixed-price delivery order contract with a completion date of May 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,606.51 firm fixed-price delivery order is for "REFRESH PLUS 0.5% EYE DROPS 30S", a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD4Q1
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of REFRESH PLUS 0.5% EYE DROPS UD 50S. The firm-fixed-price delivery order, valued at $1,050.72, has an ultimate completion date of August 27, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for the provision of a wide range of pharmaceutical and medical supplies to support federal healthcare programs and facilities.

Generated 11/25/24, 9:31 AM